Journal
JOURNAL OF ORGANIC CHEMISTRY
Volume 86, Issue 13, Pages 8843-8850Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.joc.1c00761
Keywords
-
Categories
Funding
- Ministry of Business Innovation Employment [UOOX1904]
- NIH [P30AI124414]
- New Zealand Ministry of Business, Innovation & Employment (MBIE) [UOOX1904] Funding Source: New Zealand Ministry of Business, Innovation & Employment (MBIE)
Ask authors/readers for more resources
ddhCTP is a novel antiviral molecule that acts as a chain terminator of flavivirus and SARS-CoV-2 RNA-dependent RNA polymerases. Limited access to this promising antiviral has hindered further biophysical studies, but a robust synthesis method has been developed to prepare ddhCTP on a gram scale.
3'-Deoxy-3',4'-didehydro- cytidine triphosphate (ddhCTP) is a novel antiviral molecule produced by the enzyme viperin as part of the innate immune response. ddhCTP has been shown to act as an obligate chain terminator of flavivirus and SARS-CoV-2 RNA-dependent RNA polymerases; however, further biophysical studies have been precluded by limited access to this promising antiviral. Herein, we report a robust and scalable synthesis of ddhCTP as well as the mono- and diphosphates ddhCMP and ddhCDP, respectively. Identification of a 2'-silyl ether protection strategy enabled selective synthesis and facile purification of the 5'-triphosphate, culminating in the preparation of ddhCTP on a gram scale.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available